Clinical trial

Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC

NCT03085966

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-02-27

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2017-02-27Date precision: day

Registry last updated2017-03-21

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Castration-resistant Prostate Cancerunresolved

Interventions

autologous immune cell therapyBIOLOGICAL

Sponsors & collaborators

Shanghai AbelZeta Ltd.lead sponsor

Fudan Universitycollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03085966 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.